Literature DB >> 18053438

Azithromycin for PID beats doxycycline on all counts.

Kate Rowland1, Bernard Ewigman.   

Abstract

Entities:  

Year:  2007        PMID： 18053438      PMCID： PMC3183833     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  9 in total

1.  Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin.

Authors:  C D Adair; M Gunter; T G Stovall; G McElroy; J C Veille; J M Ernest
Journal:  Obstet Gynecol       Date:  1998-02       Impact factor: 7.661

2.  Sexually transmitted diseases treatment guidelines, 2006.

Authors:  Kimberly A Workowski; Stuart M Berman
Journal:  MMWR Recomm Rep       Date:  2006-08-04

3.  Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-04-13       Impact factor: 17.586

4.  Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.

Authors:  Roberta B Ness; David E Soper; Robert L Holley; Jeffrey Peipert; Hugh Randall; Richard L Sweet; Steven J Sondheimer; Susan L Hendrix; Antonio Amortegui; Giuliana Trucco; Thomas Songer; Judith R Lave; Sharon L Hillier; Debra C Bass; Sheryl F Kelsey
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

5.  Adherence to oral therapies in pelvic inflammatory disease.

Authors:  Jacqueline Dunbar-Jacob; Susan M Sereika; Susan M Foley; Debra C Bass; Roberta B Ness
Journal:  J Womens Health (Larchmt)       Date:  2004-04       Impact factor: 2.681

6.  Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis.

Authors:  D Magid; J M Douglas; J S Schwartz
Journal:  Ann Intern Med       Date:  1996-02-15       Impact factor: 25.391

7.  Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease.

Authors:  C D Bevan; G L Ridgway; C D Rothermel
Journal:  J Int Med Res       Date:  2003 Jan-Feb       Impact factor: 1.671

8.  Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials.

Authors:  Chuen-Yen Lau; Azhar K Qureshi
Journal:  Sex Transm Dis       Date:  2002-09       Impact factor: 2.830

9.  Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial.

Authors:  Ricardo Francalacci Savaris; Luciana Montagna Teixeira; Tobias Garcia Torres; Maria Isabel Albano Edelweiss; Jeanne Moncada; Julius Schachter
Journal:  Obstet Gynecol       Date:  2007-07       Impact factor: 7.661
  9 in total
  1 in total

1.  Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse.

Authors:  Jiongyu Ren; Rebecca Murray; Cynthia S Wong; Jilong Qin; Michael Chen; Makrina Totsika; Andrew D Riddell; Andrea Warwick; Nicholas Rukin; Maria A Woodruff
Journal:  Polymers (Basel)       Date:  2022-02-16       Impact factor: 4.329
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.